• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number JHJR060202J
Device Problem Insufficient Information (3190)
Patient Problem Arteriosclerosis/ Atherosclerosis (4437)
Event Date 08/26/2021
Event Type  Injury  
Event Description
The following literature was reviewed: hiroshi miura, et al.A successful case of viabahn placement in emergency ivr for postoperative bleeding from pancreatic head cancer.Program and abstracts of the 57th autumn assembly of the japan radiological society.2021; s467.A woman in her 70s had massive bleeding through drainage on the 9th day after surgery for pancreatic head cancer.An angiography showed spasm in the hepatic artery, and pseudoaneurysm formation and extravasation were also noted.Hemostasis was attempted for a temporal period using a micro-balloon catheter (attendant® 4mm) and the shrinkage of the hepatic artery was improved.A destination® (90 cm) sheath was inserted into the origin of the celiac artery via the left brachial artery because it was difficult to advance the device via the aorta for an anatomical reason.Gore® viabahn® endoprosthesis (6 mm x 25 mm) was implanted using a v-18 guidewire into the hepatic artery.An immediate angiography showed disappearance of the pseudoaneurysm and preservation of the hepatic artery blood flow.On an unknown date, a follow-up ct scan showed no recurrence of the pseudoaneurysm, but the viabahn® was occluded and infarction was observed in the lateral zone of the left hepatic lobe.After 2 months of treatment, the patient was discharged from the hospital.Emergency viabahn® implantation for postoperative bleeding of biliary tract diseases may be an important lifesaving technique as interventional radiology (ivr).
 
Manufacturer Narrative
Date of publication was used for event date due to no implant date being provided.Due to an unknown lot/serial number and no device return, an investigation could not be performed.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Manufacturer Narrative
" a successful case of viabahn placement in emergency ivr for postoperative bleeding from pancreatic head cancer." hiroshi miura, et al.Program and abstracts of the 57th autumn assembly of the japan radiological society.2021; s467.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
spencer deboard
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13172123
MDR Text Key286266558
Report Number2017233-2022-02654
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberJHJR060202J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/08/2021
Initial Date FDA Received01/05/2022
Supplement Dates Manufacturer Received03/21/2022
Supplement Dates FDA Received03/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage A
Patient Sequence Number1
Patient Outcome(s) Other; Other;
Patient Age70 YR
Patient SexFemale
-
-